The patient’s age, disease stage at the time of diagnosis, presence of MYCN amplification in NB cells, deletion of the 11q chromosome, histological characteristics, and ploidy have become crucial factors for stratifying risk groups in NB patients (43). Here, MYCN is linked to neuroblastoma.